Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Dr. Christina Poh, a hematologist-oncologist, mentioned the medical trial that led to the FDA approval of Monjuvi (tafasitamab-cxix) together with Revlimid (lenalidomide) and...
Dr. Nicholas James shares why it’s essential to determine which sufferers with high-risk, non-metastatic prostate most cancers will profit from intensified remedy.Figuring out...
Troy Anderson, a follicular lymphoma survivor, shared how becoming a member of a scientific trial at Fred Hutch, positioned in Seattle, Washington, modified...
13 years after cervical most cancers, I’ve discovered energy in therapeutic, grief in silence, and hope in sharing the quiet truths of survivorship.As...
